Epigral Ltd Q1 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/jj53f2459is0fe3566qwge1u.pdf

Key Takeaways


The Downcycle: Realization, Inventory & Demand

Maulik Patel: "Quarter 1 is going to be, I think, the worst quarter since we have started manufacturing. It is not going to remain the same forever."

Diversification Payoff: Downstream Mix Shift


Margins & Profitability: The Walk to Recovery


Expansion Pipeline: Volume Growth Levers

Maulik Patel: "You are right that the time when we have finalized the Rs. 5,000 crores, it may be here or there. It may not be exact Rs. 5,000 crores. Sometimes in down cycle like current situation, it may be Rs. 4,500 crores or Rs. 4,600 crores kind of thing. But yes, normally on a longer-term point of view, we believe that we will achieve those numbers."

Competitive Position & Market Structure

B Ravi: "as far as MFL is concerned, the kind of an input cost that they have and the infrastructure they already have built and integrated, they will be the last one to be losing. Even if everybody else loses, they will be the last to lose."

Energy & Infrastructure

Maulik Patel: "But now onwards, I think in the future, I would say at least you can invest up to 30% to 40% of your requirement by green energy, not more than that. None of the industry can afford 100% on the green base possible. It is not possible in the chemical industry, at least."

Guidance & Commitments

CommitmentSpecificsTimeline
Full-year absolute EBITDARs. 450–500 croresFY24
Debt to EBITDARemain less than 2xOngoing
CPVC expansion commissioning45,000 TPA capacity onlineQ4 FY24
ECH utilizationReach optimum levelQ3 FY24
Chlorotoluene revenue startSlow and gradual contribution beginsFY25
Revenue targetRs. 5,000 crores (may be Rs. 4,500–4,600 crores in downcycle)By 2027
EBITDA margin aspiration28% plus or minusLonger-term
Pre-tax ROCE aspiration25%Longer-term
In-house chlorine consumptionReach ~75%1.5–2 years

Key Metrics

MetricQ1 FY24
RevenueDown 15% YoY, realization down ~26% YoY, volume up 11% YoY
Revenue from derivatives and specialty chemicals38% of total revenue, up from 21% in Q1 FY23
EBITDA (absolute, FY24 guidance)₹450–500 cr expected for full year FY24
EBITDA margin (FY24 guidance)~25–26% expected for full year; Q3 onwards improvement anticipated
PATDe-grew YoY, impacted by lower realizations and high-cost inventory consumption
Trailing 12-month ROCE25% as on 30 June 2023
Trailing 12-month ROE29% as on 30 June 2023
Net debt₹902 cr as on 30 June 2023, versus ₹863 cr as on 31 March 2023
Net debt to EBITDA1.5x in Q1 FY24, versus 1.3x in Q4 FY23
Net debt to equity0.8x in Q1 FY24
CAPEX spend₹108 cr in Q1 FY24
Overall plant capacity utilization~70%
Caustic soda capacity utilization~70–75%
Caustic soda ECU realization~₹30,500 per ton
Caustic soda realization changeDropped ~40% YoY
Chlorine consumption in-house~65%, targeting 75% in 1.5–2 years, eventually 85%
CPVC Indian market size~2,25,000 tonnes per annum, growing at double digits
CPVC Indian manufacturing capacity40 KTPA, expanding to 75 KTPA
Revenue target by 2027₹5,000 cr
Pre-tax ROCE target25%
Debt to EBITDA expected rangeLess than 2x
FY24 debt repayment~₹240 cr
Hybrid power plant commissioned18.34 MW in Q1 FY24